Market revenue in 2023 | USD 21.0 million |
Market revenue in 2030 | USD 38.4 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.67% in 2023. Horizon Databook has segmented the India biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Global medical device companies commonly outsource their manufacturing services to India. Lower costs of labor, improved infrastructure, and a large number of technical experts are some of the major drivers for the growth of the medical device outsourcing market in this country.
In addition, India is one of the most popular locations for outsourcing manufacturing services because of the rise in government financing for R&D to expedite new product development. Hence, outsourcing various services to emerging countries such as India is expected to boost the market in the country and improve the competition among market players in India In May 2023, the Indian Government introduced a program to support the enhancement of existing and newly established medical device clusters.
This initiative is designed to fortify these clusters by offering financial assistance and promoting the establishment or reinforcement of testing laboratories for medical devices, thereby enhancing quality and fostering sustainable growth.
Horizon Databook provides a detailed overview of country-level data and insights on the India biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into India biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account